These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17617901)

  • 21. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
    Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
    N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose selenium for critically ill patients with systemic inflammation: pharmacokinetics and pharmacodynamics of selenious acid: a pilot study.
    Manzanares W; Biestro A; Galusso F; Torre MH; Mañáy N; Facchin G; Hardy G
    Nutrition; 2010 Jun; 26(6):634-40. PubMed ID: 20080034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
    JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.
    Boerma EC; Koopmans M; Konijn A; Kaiferova K; Bakker AJ; van Roon EN; Buter H; Bruins N; Egbers PH; Gerritsen RT; Koetsier PM; Kingma WP; Kuiper MA; Ince C
    Crit Care Med; 2010 Jan; 38(1):93-100. PubMed ID: 19730258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study.
    Pappalardo F; Crivellari M; Di Prima AL; Agracheva N; Celinska-Spodar M; Lembo R; Taddeo D; Landoni G; Zangrillo A
    Intensive Care Med; 2016 Nov; 42(11):1706-1714. PubMed ID: 27344436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
    Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R
    JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial.
    Legrand M; Oufella HA; De Backer D; Duranteau J; Leone M; Levy B; Rossignol P; Vicaut E; Dépret F;
    Trials; 2020 Jul; 21(1):601. PubMed ID: 32611377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial.
    Petsakul S; Morakul S; Tangsujaritvijit V; Kunawut P; Singhatas P; Sanguanwit P
    BMC Anesthesiol; 2020 Nov; 20(1):280. PubMed ID: 33167911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
    Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
    Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
    Schmoelz M; Schelling G; Dunker M; Irlbeck M
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock.
    Pontes-Arruda A; Aragão AM; Albuquerque JD
    Crit Care Med; 2006 Sep; 34(9):2325-33. PubMed ID: 16850002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaconutrition with selenium in critically ill patients: what do we know?
    Manzanares W; Langlois PL; Heyland DK
    Nutr Clin Pract; 2015 Feb; 30(1):34-43. PubMed ID: 25524883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.
    Abraham E; Anzueto A; Gutierrez G; Tessler S; San Pedro G; Wunderink R; Dal Nogare A; Nasraway S; Berman S; Cooney R; Levy H; Baughman R; Rumbak M; Light RB; Poole L; Allred R; Constant J; Pennington J; Porter S
    Lancet; 1998 Mar; 351(9107):929-33. PubMed ID: 9734938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.
    Dhainaut JF; Antonelli M; Wright P; Desachy A; Reignier J; Lavoue S; Charpentier J; Belger M; Cobas-Meyer M; Maier C; Mignini MA; Janes J
    Intensive Care Med; 2009 Jul; 35(7):1187-95. PubMed ID: 19263034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of High-dose Parenteral Sodium Selenite in Critically Ill Patients following Sepsis: A Clinical and Mechanistic Study.
    Chelkeba L; Ahmadi A; Abdollahi M; Najafi A; Ghadimi MH; Mosaed R; Mojtahedzadeh M
    Indian J Crit Care Med; 2017 May; 21(5):287-293. PubMed ID: 28584432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
    Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
    Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis.
    Sakr Y; Maia VP; Santos C; Stracke J; Zeidan M; Bayer O; Reinhart K
    Crit Care; 2014 Apr; 18(2):R68. PubMed ID: 24716537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.